
Safety and disease monitoring biomarkers in Duchenne muscular …
Aim: Evaluate the utility of glutamate dehydrogenase (GLDH) and cardiac troponin I as safety biomarkers, and creatine kinase and muscle injury panel as muscle health biomarkers in Duchenne muscular dystrophy. Patients & methods: Data were collected during a Phase II trial of domagrozumab.
Synuclein-One study: skin biopsy detection of phosphorylated α ...
The large, multi-center Synuclein-One study will determine the sensitivity, specificity, accuracy and precision of α-synuclein detection within punch skin biopsies in patients with clinically established synucleinopathies using standardized, robust …
Accuracy of cytokeratin 19 fragment in the diagnosis of ... - PubMed
Aim: CYFRA21-1 is a biomarker of cancer and has a promising future in the diagnosis of bladder cancer. The purpose of this study was to assess the diagnostic accuracy of CYFRA21-1 for …
Multiple Time-Point Assessment of Lncrna MEG3 Shows Potential …
2021年9月7日 · Results: LncRNA MEG3 expression was downregulated, and it negatively correlated with lesion joints, inflammation and disease activity in RA patients. Moreover, lncRNA MEG3 expression was increased during treatment; meanwhile its increment correlated with treatment response and remission.
BMM Summer Course 2021 - YouTube
What are the computations underlying primate vs. machine vision?
Copy Number Alteration Signatures As Biomarkers in Cancer: A …
2022年2月23日 · Within certain cancers, extensive copy number alterations (CNAs) contribute to a complex and heterogenic genomic profile. This makes it difficult to understand and unravel the distinct molecular dynamics shaping the disease while …
CHEK1: A Hub Gene Related to Poor Prognosis for Lung …
Aim: The study aims to pinpoint hub genes and investigate their functions in order to gain insightful understandings of lung adenocarcinoma (LUAD).
BMM Testlabs South Africa achieves 20% growth in 2021 | bmm …
2022年3月7日 · BMM Testlabs is pleased to report business growth of over 20% in 2021 in South Africa. Kirk White, EVP and General Manager, APAC and Africa, stated, “2021 was an excellent year for BMM in South Africa, servicing both regional and European customers.
HOXA9-methylated DNA as a diagnostic biomarker of ovarian
Results: Meth-HOXA9 was detected in 93% (82/88) and 88% (14/16) of ovarian cancer and borderline tumors, respectively. In patients with benign ovarian tumors meth-HOXA9 was detected in 17% (3/18). Using receiver operating characteristic (ROC) analysis meth-HOXA9 had a diagnostic accuracy of 98%.
BMM Convention 2026
SMM will be hosting the BMM convention after 19 years at the Seattle Convention Center from August 7 to 9, 2026. SMM was announced official 2026 BMM Convention Host Mandal at BMM's recent biannual convention in San Jose, CA.